Clinical trial
Interventional Multicentre Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation
NCT03076151 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interventional Multicentre Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation
- Lead sponsor
- University Hospital, Limoges
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 12, 2018
- Completion date
- July 31, 2019
- Enrollment
- 30 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
kidney, pharmacokinetic, transplantation